Hsa-mir-122 Overexpression Stable Cell Line - HeLa

MicroRNA-122 (hsa-miR-122) is a highly conserved, tissue-specific non-coding RNA that constitutes approximately 70% of the total microRNA population in the adult human liver. It serves as a central regulatory node in maintaining hepatic homeostasis, heavily influencing lipid and cholesterol metabolism, systemic iron levels, and hepatocyte differentiation. Biologically, miR-122 functions as a potent tumor suppressor in hepatocellular carcinoma (HCC), where its clinical downregulation is directly correlated with aggressive metastasis and poor patient prognosis. Uniquely, miR-122 is also an absolute prerequisite host factor for the Hepatitis C Virus (HCV). It binds specifically to two adjacent sites on the 5' untranslated region (UTR) of the HCV RNA genome, physically stabilizing the viral RNA and actively promoting its replication. HeLa, a foundational human cervical adenocarcinoma cell line renowned for its robust proliferative capacity and epithelial morphology, does not naturally express endogenous miR-122. The Hsa-mir-122 Overexpression Stable Cell Line - HeLa bridges this biological gap through the stable genetic integration and constitutive transcription of the hsa-miR-122 precursor.

The constitutive overexpression of hsa-miR-122 transforms the standard HeLa lineage into a specialized, highly controlled in vitro platform for virology and molecular oncology research. Because wild-type HeLa cells completely lack a native miR-122 background, this engineered cell line provides a pristine environment devoid of endogenous interference. This establishes an ideal model for identifying, characterizing, and validating direct downstream mRNA targets of miR-122 using advanced transcriptomic profiling or functional reporter assays. In the field of infectious disease research, this stable cell line is exceptionally valuable. The exogenous expression of miR-122 renders the traditionally non-permissive HeLa cells capable of supporting HCV replicon systems and translation assays, allowing virologists to rigorously dissect the mechanisms of viral replication outside of standard, heavily utilized hepatoma models like Huh-7. Additionally, this highly reproducible platform is frequently employed for the high-throughput screening and validation of sequence-specific anti-miRNA oligonucleotides (antagomirs) and next-generation antiviral therapeutics.